TomoTherapy has entered into an agreement to acquire privately held linear accelerator manufacturer Chengdu Twin Peak Accelerator Technology Inc., based in Chengdu.
Fred Robertson, CEO of TomoTherapy says, "We are very pleased to make this announcement. The acquisition of Twin Peak represents a substantial advance in our ability to control the quality and features of our products. This is also a piece of our longer-term strategy of reducing the cost of the Hi·Art treatment system to improve margins."
A linear accelerator is a key component in radiation therapy systems, used to create high-energy x-rays for cancer treatments. The linear accelerators designed, developed and manufactured by Twin Peak will be used to supplement TomoTherapy's existing supply source.
The financial terms of the transaction were not disclosed.